Trial intelligence / Profile preview

Effectiveness of Pascoflair on test anxiety using quantitative EEG during examination stress

2014-003369-50Phase 4Completed

Sponsor
Pascoe
Start
Jan 2015
Countries
1
01

Overview

Phase 4, single-arm trial of passiflora incarnata in test anxiety, None and anxiety disorder, sponsored by Pascoe. Primary endpoint: Anxiolytic effect measured by quantitative EEG and eye-tracking during examination stress. Started Jan 2015; status: completed.

02

Drugs

passiflora incarnata
03

Conditions

test anxietyanxiety disorder

Beyond the preview

Go deeper on 2014-003369-50.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003369-50.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call